Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in J Biol Chem

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    October 2023
  1. QIU T, Hou L, Zhao L, Wang X, et al
    SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1.
    J Biol Chem. 2023 Oct 12:105351. doi: 10.1016/j.jbc.2023.105351.
    PubMed     Abstract available


    July 2023
  2. HOGSTROM JM, Cruz KA, Selfors LM, Ward MN, et al
    Simultaneous isolation of hormone receptor positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms.
    J Biol Chem. 2023 Jul 7:105021. doi: 10.1016/j.jbc.2023.105021.
    PubMed     Abstract available


    May 2023
  3. BONHAM CA, Mandati V, Singh RK, Pappin DJ, et al
    Coupling substrate-trapping with proximity-labeling to identify protein tyrosine phosphatase PTP1B signaling networks.
    J Biol Chem. 2023;299:104582.
    PubMed     Abstract available


    January 2023
  4. WANG W, Zhang Z, Zhao M, Wang Y, et al
    Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway.
    J Biol Chem. 2023;299:102812.
    PubMed     Abstract available


  5. VALLET A, El Ezzy M, Diennet M, Haidar S, et al
    The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens.
    J Biol Chem. 2023;299:102757.
    PubMed     Abstract available


    December 2022
  6. DONAHUE K, Xie H, Li M, Gao A, et al
    Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment.
    J Biol Chem. 2022;298:102700.
    PubMed     Abstract available


  7. SLADE L, Biswas D, Kienesberger PC, Pulinilkunnil T, et al
    Loss of transcription factor EB dysregulates the G1/S transition and DNA replication in mammary epithelial cells.
    J Biol Chem. 2022;298:102692.
    PubMed     Abstract available


    November 2022
  8. ALWANIAN WM, Vlajic K, Bie W, Kajdacsy-Balla A, et al
    Protein tyrosine kinase 6 regulates activation of SRC kinase.
    J Biol Chem. 2022;298:102584.
    PubMed     Abstract available


    October 2022
  9. WANG J, Liu X, Li P, Wang J, et al
    Long non-coding RNA HOTAIR regulates the stemness of breast cancer cells via activation of the NF-kappaB signaling pathway.
    J Biol Chem. 2022 Oct 20:102630. doi: 10.1016/j.jbc.2022.102630.
    PubMed     Abstract available


  10. GUO Q, Qiu Y, Liu Y, He Y, et al
    Cell adhesion molecule CD44v10 promotes stem-like properties in triple-negative breast cancer cells via glucose transporter GLUT1-mediated glycolysis.
    J Biol Chem. 2022 Oct 12:102588. doi: 10.1016/j.jbc.2022.102588.
    PubMed     Abstract available


    August 2022
  11. SU K, Collins MP, McGuire CM, Alshagawi MA, et al
    Isoform a4 of the vacuolar ATPase a subunit promotes 4T1-12B breast cancer cell-dependent tumor growth and metastasis in vivo.
    J Biol Chem. 2022 Aug 18:102395. doi: 10.1016/j.jbc.2022.102395.
    PubMed     Abstract available


  12. HAWORTH AS, Hodges SL, Capatina AL, Isom LL, et al
    Subcellular dynamics and functional activity of the cleaved intracellular domain of the Na(+) channel beta1 subunit.
    J Biol Chem. 2022;298:102174.
    PubMed     Abstract available


    July 2022
  13. AL KHAMICI H, Sanchez VC, Yan H, Cataisson C, et al
    The oxidoreductase CLIC4 is required to maintain mitochondrial function and resistance to exogenous oxidants in breast cancer cells.
    J Biol Chem. 2022 Jul 18:102275. doi: 10.1016/j.jbc.2022.102275.
    PubMed     Abstract available


    June 2022
  14. JI R, Shi Q, Cao Y, Zhang J, et al
    Alternative splicing of the human rhomboid family-1 gene RHBDF1 inhibits epidermal growth factor receptor activation.
    J Biol Chem. 2022;298:102033.
    PubMed     Abstract available


    May 2022
  15. ZHANG X, Zhang R, Hou C, He R, et al
    FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
    J Biol Chem. 2022 May 31:102082. doi: 10.1016/j.jbc.2022.102082.
    PubMed     Abstract available


  16. AKIMOTO M, Susa T, Okudaira N, Hisaki H, et al
    A Novel LncRNA PTH-AS Upregulates Interferon-Related DNA damage resistance Signature genes and Promotes Metastasis in Human Breast Cancer Xenografts.
    J Biol Chem. 2022 May 23:102065. doi: 10.1016/j.jbc.2022.102065.
    PubMed     Abstract available


    April 2022
  17. LI Q, Zhong X, Yao W, Yu J, et al
    Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity.
    J Biol Chem. 2022;298:101753.
    PubMed     Abstract available


    March 2022
  18. CHA JH, Chan LC, Wang YN, Chu YY, et al
    Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer.
    J Biol Chem. 2022 Mar 9:101817. doi: 10.1016/j.jbc.2022.101817.
    PubMed     Abstract available


  19. MEDEIROS PJ, Pascetta SA, Kirsh SM, Al-Khazraji BK, et al
    Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation.
    J Biol Chem. 2022;298:101645.
    PubMed     Abstract available


    February 2022
  20. EAST MP, Johnson GL
    Adaptive chromatin remodeling and transcriptional changes of the functional kinome in tumor cells in response to targeted kinase inhibition.
    J Biol Chem. 2022;298:101525.
    PubMed     Abstract available


    January 2022
  21. ZHANG S, Wang R, Wang X, Guo X, et al
    HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer.
    J Biol Chem. 2022 Jan 27:101644. doi: 10.1016/j.jbc.2022.101644.
    PubMed     Abstract available


  22. KAWASE N, Sugihara A, Kajiwara K, Hiroshima M, et al
    SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells.
    J Biol Chem. 2022 Jan 24:101630. doi: 10.1016/j.jbc.2022.101630.
    PubMed     Abstract available


    November 2021
  23. WANG J, Dong Y, Ma H, Wu L, et al
    The Deubiquitinase USP28 Stabilizes Expression of RecQ Family Helicases and Maintains the Viability of Triple Negative Breast Cancer Cells.
    J Biol Chem. 2021 Nov 22:101443. doi: 10.1016/j.jbc.2021.101443.
    PubMed     Abstract available


    September 2021
  24. MANNE RK, Agrawal Y, Malonia SK, Banday S, et al
    FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX.
    J Biol Chem. 2021 Sep 26:101253. doi: 10.1016/j.jbc.2021.101253.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.